{"status": "Ok", "redirect_url": "https://www.businesswire.com/news/home/20260827232786/en/Natera-and-Angiex-Partner-to-Assess-Response-to-Investigational-Nuclear-Delivered-Antibody-Drug-Conjugate%E2%84%A2-Using-Signatera%E2%84%A2", "message": "News view counter 904389 successfully enlarged"}